Global Olmesartan Medoxomil (CAS 144689-63-4) Market 2016 - Daiichi Sankyo, Taj Pharmaceuticals, Divis Laboratories, Amoli Organics,Lupin, Zhejiang Tianyu, Zhuhai Rundu

Olmesartan medoxomil, the medoxomil ester of olmesartan, is novel and oral antagonist of angiotensin II TYPE-1 receptor (AT1 receptor) with an inhibition constant IC50 of 33 nmol/L. Through oral administration, olmesartan medoxomil is rapidly absorbed by the gastrointestinal tract converting to its active metabolite olmesartan, whose inhibition constant IC50 towards AT1 receptor is 8 nmol/L. The esterification of olmesartan with medoxomil moiety is just to improve its water solubility (from 4.5% to 28.6%). Olmesartan medoxomil is used for the treatment of hypertension, in which olmesartan dose-dependently reduces the blood pressure through arterial vasodilation and reducing sodium retention.

Download sample report at http://www.fiormarkets.com/report-detail/10894/request-sample

This report provides detailed analysis of worldwide markets for Olmesartan Medoxomil (CAS 144689-63-4) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Olmesartan Medoxomil (CAS 144689-63-4) market and further lays out an analysis of the factors influencing the supply/demand for Olmesartan Medoxomil (CAS 144689-63-4), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Global Olmesartan Medoxomil (CAS 144689-63-4) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Olmesartan Medoxomil (CAS 144689-63-4) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies.

Access full report at http://www.fiormarkets.com/report/global-olmesartan-medoxomil-cas-144689-63-4-market-outlook-2016-2021-10894.html

The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Olmesartan Medoxomil (CAS 144689-63-4) market are Daiichi Sankyo (Japan), Taj Pharmaceuticals (India), Divis Laboratories (India), Amoli Organics (India),Lupin (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), Lianyungang Runzhong (China), HEC (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Olmesartan Medoxomil (CAS 144689-63-4) industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.